Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Free Cash Flow (2019 - 2026)

BioScience Health Innovations has reported Free Cash Flow over the past 8 years, most recently at -$552107.0 for Q1 2026.

  • Quarterly Free Cash Flow fell 268.17% to -$552107.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$708238.0 through Mar 2026, down 277.26% year-over-year, with the annual reading at $172178.0 for FY2025, 642.53% up from the prior year.
  • Free Cash Flow was -$552107.0 for Q1 2026 at BioScience Health Innovations, down from -$100696.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $328309.0 in Q1 2025 and troughed at -$552107.0 in Q1 2026.
  • The 5-year median for Free Cash Flow is -$50305.0 (2024), against an average of -$47834.7.
  • The largest YoY upside for Free Cash Flow was 783.41% in 2025 against a maximum downside of 751.78% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$27910.0 in 2022, then plummeted by 102.28% to -$56457.0 in 2023, then increased by 10.9% to -$50305.0 in 2024, then tumbled by 100.17% to -$100696.0 in 2025, then plummeted by 448.29% to -$552107.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Free Cash Flow are -$552107.0 (Q1 2026), -$100696.0 (Q4 2025), and -$340445.0 (Q3 2025).